|24.18||-2.11||-8.03%||Vol 356.73K||1Y Perf -79.48%|
|Jun 28th, 2022 16:00 DELAYED|
|- -||- -%|
|Target Price||57.00||Analyst Rating||Moderate Buy 2.50|
|Potential %||135.73||Finscreener Ranking||★★★ 49.47|
|Insiders Trans % 3/6/12 mo.||-43/-76/-90||Value Ranking||★★ 46.10|
|Insiders Value % 3/6/12 mo.||-89/18/-41||Growth Ranking||★★+ 47.72|
|Insiders Shares Cnt. % 3/6/12 mo.||-85/5/-38||Income Ranking||— -|
|Price Range Ratio 52W %||2.60||Earnings Rating||Strong Buy|
|Market Cap||824.90M||Earnings Date||2nd Aug 2022|
Today's Price Range
|Earnings History||Estimate||Reported||Surprise %|
|Earnings Per End||Estimate||Revision %||Trend|
|Next Report Date||2nd Aug 2022|
|Estimated EPS Next Report||-0.94|
|EPS Growth Next 5 Years %||-|
|Avg. Weekly Volume||480.01K|
|Avg. Monthly Volume||444.91K|
|Avg. Quarterly Volume||473.98K|
Cardlytics Inc. (NASDAQ: CDLX) stock closed at 26.29 per share at the end of the most recent trading day (a -2.34% change compared to the prior day closing price) with a volume of 318.48K shares and market capitalization of 824.90M. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Interactive Media industry, Communication Services sector and employs 486 people. Cardlytics Inc. CEO is Lynne M. Laube.
The one-year performance of Cardlytics Inc. stock is -79.48%, while year-to-date (YTD) performance is -60.22%. CDLX stock has a five-year performance of %. Its 52-week range is between 21.22 and 134.91, which gives CDLX stock a 52-week price range ratio of 2.60%
Cardlytics Inc. currently has a PE ratio of -12.30, a price-to-book (PB) ratio of 1.29, a price-to-sale (PS) ratio of 3.18, a price to cashflow ratio of 291.80, a PEG ratio of 2.32, a ROA of -6.43%, a ROC of -6.50% and a ROE of -9.98%. The company’s profit margin is -24.39%, its EBITDA margin is -8.80%, and its revenue ttm is $281.81 Million , which makes it $8.26 revenue per share.
Of the last four earnings reports from Cardlytics Inc., there were 3 positive earnings surprise and 1 negative earnings surprise. The company has EPS estimate of $-0.94 for the next earnings report. Cardlytics Inc.’s next earnings report date is 02nd Aug 2022.
The consensus rating of Wall Street analysts for Cardlytics Inc. is Moderate Buy (2.5), with a target price of $57, which is +135.73% compared to the current price. The earnings rating for Cardlytics Inc. stock is Strong Buy (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).
Cardlytics Inc. has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.
Cardlytics Inc. has a Neutral technical analysis rating based on Technical Indicators (ADX : 11.98, ATR14 : 2.17, CCI20 : 5.20, Chaikin Money Flow : -0.03, MACD : -1.58, Money Flow Index : 57.47, ROC : -9.28, RSI : 45.96, STOCH (14,3) : 58.75, STOCH RSI : 0.89, UO : 52.08, Williams %R : -41.25), Simple Moving Averages and Exponential Moving Averages.
Aggregated Insider Trades of Cardlytics Inc. in the last 12-months were: Andrew Christiansen (Option Excercise at a value of $0), Andrew Christiansen (Sold 16 592 shares of value $916 372 ), Clifford Sosin (Buy at a value of $10 569 151), David L. Adams (Option Excercise at a value of $0), Jessica Jensen (Option Excercise at a value of $0), John L. Klinck (Option Excercise at a value of $0), John V. Balen (Buy at a value of $419 924), John V. Balen (Option Excercise at a value of $0), Kirk L. Somers (Option Excercise at a value of $1 826), Kirk L. Somers (Sold 31 618 shares of value $2 081 109 ), Lynne M. Laube (Option Excercise at a value of $110 280), Lynne M. Laube (Sold 49 553 shares of value $3 356 967 ), Mark A. Johnson (Option Excercise at a value of $0), Scott D. Grimes (Option Excercise at a value of $0), Scott D. Grimes (Sold 151 982 shares of value $10 834 891 ), Scott Grimes (Option Excercise at a value of $0), Scott Grimes (Sold 127 122 shares of value $9 174 780 ), Tony Pavese (Option Excercise at a value of $0)
Copyright © 2016-2022 Finscreener.org. All Rights Reserved.
Disclaimer: Before deciding to trade you should carefully consider your investment objectives, level of experience and your risk appetite. Forex and Tradegate data is a real-time with a 30 second refresh. Prices may not be accurate and may differ from the actual market price. Prices on the website are indicative and solely for informational purposes, not for trading purposes or advice. Please be aware of the risks associated with trading the on financial markets, it is one of the riskiest investment forms. Past performance does not guarantee future profits. We take no responsibility for any losses that may arise as a result of the data contained on this website. The content and the website are provided "as is", without any warranties. In no event will Finscreener.org, its employees, owners, directors, affiliates, partners, data provider, third party or anyone else liable to anyone else for any decision made regarding information on this website.
eToro USA LLC does not offer CFDs and makes no representation and assumes no liability as to the accuracy or completeness of the content of this publication, which has been prepared by our partner utilizing publicly available non-entity specific information about eToro. Your capital is at risk.
This could take some time, please wait.